LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
מצבים רפואיים
Hypertrophic Cardiomyopathy (HCM)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
CHU Angers, Angers, France
Contact: Study coordinator (Loïc BIERE)CHU Bordeaux Haut-Levêque, Bordeaux, France
Contact: Study coordinator (Patricia Reant, Pr)CHU Brest - Hôpital La Cavale Blanche, Brest, France
Contact: Study coordinator (Ombeline PAGLIA)CHU Caen, Caen, France
Contact: Study coordinator (Fabien LABOMBARDA)CHU Dijon - Hôpital François Mitterrand, Dijon, France
Contact: Study coordinator (Jean-Christophe EICHER)CHU Grenoble Alpes, Grenoble, France
Contact: Study coordinator (Gilles Barone-Rochette, Pr)CHU Lille, Lille, France
Contact: Study coordinator (RIDON Hélène)APHM - Hôpital La Timone, Marseille, France
Contact: Study coordinator (HABIB Gilbert)CHU de Nantes -Hôpital Nord Laennec, Nantes, France
Contact: Study coordinator (Nicolas PIRIOU)AP-HP Höpital la Pitié-Salpétrière, Paris, France
Contact: Study coordinator (Philippe CHARRON)APHP Hopital Européen Georges Pompidou, Paris, France
Contact: Study coordinator (Nadia AISSAOUI)APHP, Hôpital Lariboisière, Paris, France
Contact: Study coordinator (Damien LOGEART)CHU Rennes - Hôpital Pontchaillou, Rennes, France
Contact: Study coordinator (DONAL Erwan)CHU de Rouen, Rouen, France
Contact: Study coordinator (Charles FAUVEL)CHU Rangueil Toulouse, Toulouse, France
Contact: Study coordinator (Eve Cariou)CHU de TOURS - HOPITAL TROUSSEAU, Tours, France
Contact: Study coordinator (Anne BERNARD)CHU Nancy, Vandœuvre-lès-Nancy, France
Contact: Study coordinator (Olivier HUTTIN)
מובילי המחקר
Donal Erwan
Principal Investigator
Rennes University Hospital